NASDAQ$BTTC

Black Titan Corp · Q2 2018 earnings

Q2 2018 earnings · Reported Aug 14, 2018 (8 years ago) · Investor relations

Aug 14Jun 30, 2018

Total Revenue

$605K

Previous: $77K+685.3%

EPS (adj)

-$144.00

Previous: -$612.00+76.5%

Capital Expenditures

-$5K

No prior period

Free Cash Flow

-$1.85M

Previous: -$2.52M+26.5%

Net Income

$22.6K

Previous: -$3.45M+100.7%

Operating Income

$38.5K

Previous: -$3.62M+101.1%

Gross Profit

$397K

Previous: -$2.42M+116.4%

Cash & Equivalents

$64.7K

Previous: $8.35M-99.2%

Total Assets

$4.14M

Previous: $9.41M-56.0%

Stock-Based Comp

$402K

Previous: $382K+5.2%

Titan Pharmaceuticals · Revenue · Quarterly

$605K

Q2 2018+685.3%vs Q2 2017

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation